Evidence map›Paper›PMID 29057268›Full record

ArticleBioMed research international2017

Latent Class Analysis of Noninvasive Methods and Liver Biopsy in Chronic Hepatitis C: An Approach without a Gold Standard.

Flavia F Fernandes, Hugo Perazzo, Luiz E Andrade, Alessandra Dellavance, Carlos Terra, Gustavo Pereira, João L Pereira, Frederico Campos, Maria L Ferraz, Renata M Perez

Abstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Flavia F FernandesGastroenterology and Hepatology Department, University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Hugo PerazzoLaboratory of Clinical Research in HIV, AIDS and STD (LAPCLIN-AIDS), National Institute of Infectious Diseases Evandro Chagas (INI), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.ORCID 0000-0003-0931-6418
Luiz E AndradeRheumatology Department, Federal University of São Paulo, São Paulo, SP, Brazil.
Alessandra DellavanceDepartment of Research and Development, Fleury Group, São Paulo, SP, Brazil.
Carlos TerraGastroenterology and Hepatology Department, University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Gustavo PereiraGastroenterology and Hepatology Department, Bonsucesso Federal Hospital, Rio de Janeiro, RJ, Brazil.
João L PereiraGastroenterology and Hepatology Department, Bonsucesso Federal Hospital, Rio de Janeiro, RJ, Brazil.
Frederico CamposGastroenterology and Hepatology Department, University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Maria L FerrazGastroenterology Department, Federal University of São Paulo, São Paulo, SP, Brazil.ORCID 0000-0001-8992-8494
Renata M PerezGastroenterology and Hepatology Department, University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo evaluate the applicability of the Latent Class Analysis (LCA) and accuracy of transient elastography (TE), aspartate-to-platelet-ratio-index (APRI), enhanced liver fibrosis (ELF), and liver biopsy (LB) for liver fibrosis assessment in a model without a gold standard.

methodsSignificant fibrosis was defined as TE ≥ 7.1 kPa, APRI ≥ 1.5, ELF ≥ 9.37, or LB METAVIR

results117 patients with chronic hepatitis C were included. In the LCA, for significant fibrosis the sensitivities and specificities (95% CI) were 0.92 (0.86-0.98) and 0.79 (0.72-0.86) for TE; 0.47 (0.40-0.54) and 0.99 (0.95-1.00) for APRI; 0.81 (0.74-0.88) and 0.78 (0.71-0.85) for ELF; and 0.86 (0.68-1.00) and 0.91 (0.79-1.00) for LB. For cirrhosis, the sensitivities and specificities were 0.92 (0.76-1.00) and 0.94 (0.91-0.97) for TE; 0.57 (0.37-0.77) and 0.97 (0.93-1.00) for APRI; 0.94 (0.84-1.00) and 0.88 (0.82-0.94) for ELF; and 0.30 (0.12-0.48) and 1.00 for LB.

conclusionLCA was useful to evaluate accuracy of methods for liver fibrosis staging. Sensitivities and specificities of noninvasive methods were increased in LCA compared to the use of LB as the gold standard.

Indexed as

Alanine TransaminaseAspartate AminotransferasesBiopsyElasticity Imaging TechniquesFemaleHepacivirusHepatitis C, ChronicHumansLiverLiver CirrhosisMaleMiddle AgedPlatelet CountAlanine TransaminaseAspartate Aminotransferases

Identifiers

PMID29057268
PMCPMC5615978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.